Trimeris - Mi einem KGV von 12 für 2007 viel zu billig... - 500 Beiträge pro Seite

[blb]

Auch trotz des Kursanstieges in der letzten Zeit ist Trimeris aktuell ein Schnäppchen im Biotechsektor. Letztes Quartal gab es einen Gewinn von 16 Cent, für 2007 wurden heute mindestens 1 Dollar Gewinn angekündigt. Ein aktuelles KGV von 12 ist für einen Biotechwert mehr als günstig.

Trimeris Announces Strategic Shift
TUESDAY, NOVEMBER 14, 2006 4:00 PM
- BusinessWire

MORRISVILLE, N.C., Nov 14, 2006 (BUSINESS WIRE) -- Trimeris, Inc. (TRMS) today announced that it will shift its strategic emphasis and reorganize to focus tightly on FUZEON profitability and its strength in research and early stage development. These changes are designed to significantly increase and sustain earnings from FUZEON by sharply reducing expenses. Trimeris and Roche will continue their collaboration to develop FUZEON enhancements and Next Generation Fusion Inhibitors (NGFI).

Speaking for the Trimeris Board of Directors, its Chairman, Jeffrey Lipton said, "With this change in direction of the Company, Steven Skolsky will be leaving to pursue other opportunities after making valuable contributions to the Company. We thank him for his very strong efforts and wish him well."

"Dani Bolognesi will return to the position of Chief Executive Officer and will remain Chief Scientific Officer. He and Bob Bonczek as Chief Financial Officer will lead the Company in its efforts to maximize shareholder value."

Dani Bolognesi said, "The changes in our company are designed to allow us to generate 2007 earnings well in excess of $1.00 per share and to have sustainable earnings and cash flow for the long-term. At annual earnings of $1.00 per share, we would generate approximately $20 million of additional cash flow and reach a year end 2007 cash position of about $65 million."

"We will reduce programs and our workforce as a result of these changes. We expect to have the new business structure and supporting plans in place by year-end and look forward to creating significant shareholder value with these actions. We will remain a vibrant, science-oriented company."

[blb]

[blb]

Sieht gut aus, ein weiterer Ausbruch nach oben steht wohl an!

[blb]

Aus der heutigen Meldung:

Trimeris previously announced that the restructuring plan implemented late last year was designed to achieve a strong increase in profitability and sustainable, positive earnings for the long term. Trimeris believes that it is on track to achieve its goal of generating 2007 earnings well in excess of $1.00 per share, and will provide further details on the status of its restructuring plan when Trimeris releases its complete financial results for the fourth quarter 2006 and the full year 2006 in early March, 2007.

[blb]

Der Kurs ist wieder deutlich zurückgekommen. Die Zahlen dürften bald kommen und die zukünftige Richtung vorgeben. Auch soll ein Update zum aktuellen Stand der Restrukturierung kommen!

Grüüße
blb

[blb]

Zahlen kommen heute!